Qrono is a winner of Pittsburgh Business Time’s 2017 Innovation Awards.

For more than a decade, two scientists have been working on a technology that could be a major breakthrough in the battle against cancer.

Qrono Inc. is in the development phase of creating a new pharmaceutical product, QR206, whereby micron-sized drug particles are injected directly into a tumor, disrupting the natural process of the tumor’s growth.

Read More